American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death : A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
The highest-risk subgroups, on which much attention is focused because of the magnitude of the risk of death, actually constitute only a small proportion of the total number of deaths annually. [...]a comprehensive approach to risk stratification must account for these epidemiological realities. Rev...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2008-09, Vol.52 (14), p.1179-1199 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The highest-risk subgroups, on which much attention is focused because of the magnitude of the risk of death, actually constitute only a small proportion of the total number of deaths annually. [...]a comprehensive approach to risk stratification must account for these epidemiological realities. Reviewer Employment Research Grant Other Research Support Speakers' Bureau/Honoraria Ownership Interest Consultant/Advisory Board Other Sana Al-Khatib Duke University Medtronic[dagger] Medtronic[dagger] Medtronic[dagger] None None None Jeffrey Anderson LDS Hospital BMS (platelet inhibitors)*; Sanofi (arrhythmics)*; AstraZeneca (platelet Inhibitors)* None Merck (lipid lowering; speaker)[dagger]; BMS (platelet inhibitors)*; ACEI (speaker)* None Alteon (former consultant)*; DiaDexus (LpPLA2 test consultant)*; ThomboVision (platelet test consultant)*; Proctor-Gamble (antiarrhythmia drug consultant)* None Eric Bates University of Michigan None None None None None None Alfred E. Buxton Brown Medical School None None None None None None John P. DiMarco University of Virginia Health System Guidant[dagger]; St Jude*; Medtronic*; Sanofi-Aventis* None Guidant[dagger]; St Jude*; Medtronic* None Guidant[dagger]; St Jude*; Medtronic*; CUT*; Novartis[dagger]; Schering-Plough* None Leonard S. Dreifus Retired None None Merck Pharmaceutical* None None None Gregg C. Fonarow University of California at Los Angeles Division of Cardiology Medtronic[dagger]; Guidant* None Medtronic[dagger]; Guidant* None Medtronic[dagger]; Guidant*; Biosite* None Alan Forker Mid-America Heart Pfizer[dagger]; Merck[dagger]; Takeda[dagger]; Novartis[dagger] None Merck*; Takeda* None None None Michael Gold Medical University of South Carolina Medical Center Guidant[dagger]; Medtronic[dagger]; St Jude[dagger] None Guidant[dagger]; Medtronic[dagger]; St Jude[dagger] None Guidant[dagger]; Medtronic[dagger] None Gabriel Gregoratos University of California, San Francisco None None None None None None Sharon Hunt Stanford University None None None None None None Fred M. Kusumoto Mayo Clinic Jacksonville None None Medtronic*; Boston Scientific*; EP Med Systems* None None None Rita Redberg University of California at San Francisco None None Medtronic*; St Jude* None None None David S. Rosenbaum Case Western Reserve University CardioDx[dagger] None None None Cambridge Heart Inc.[dagger] None Richard Schofield University of Florida None None AstraZeneca*; AtCor Medical*; Novartis*; Pfizer*; Scios* None Pfizer* None S |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2008.05.003 |